FDA Approves Pfizer-BioNTech COVID-19 Vaccine; Countering Terrorism In Afghanistan

The Food and Drug Administration has given full approval to the Pfizer-BioNTech COVID-19 vaccine on Monday. This could help convince people who may have resisted the vaccine and lead to more mandates. Dr. Joshua Sharfstein of Johns Hopkins Bloomberg School of Public Health joins us. And, U.S. intelligence officials are concerned that the Islamic State could attack people trying to flee Kabul following the Taliban takeover in Afghanistan. We get the latest with Charles Lister of the Countering Terrorism & Extremism Program at the Middle East Institute.